#2469 - Brigham Buhler

Bullish:

• $PEPTIDES - Peptides market opportunity as regulatory environment improves under new FDA administration, with millions already using them despite restrictions

  • “I'm truly the most optimistic I've ever been, and with reason.”

    Brigham·2:07

  • “there's millions of people right now that are taking peptides and it's radically improved their health and their vitality.”

    Joe·3:40

  • “I know the administration is still working diligently to reclassify peptides.”

    Brigham·1:46

  • “Peptides, I'm being told, are done. It's just a matter of when.”

    Brigham·58:49
• $STEMCELLS - MUSE stem cells represent breakthrough regenerative medicine opportunity with superior safety and efficacy profile compared to traditional MSCs

  • “If this is real, this is going to change everything in the regenerative space.”

    Brigham·1:49:21

  • “This is the stem cell answer that has eluded scientists for decades.”

    Brigham·1:52:40

  • “These mu cells differentiate. So they literally are regenerative cells that become the broken cell that allow your body to heal.”

    Brigham·2:10:45
• $CASHPAYHEALTH - Cash-pay preventative healthcare model growing as alternative to traditional insurance-based sick care system

  • “I really think we have the potential if we pull this off to enter a golden era of healthcare.”

    Brigham·1:36:55

  • “let's build a cash pay model that is a life raft that's an alternative, and let's build a pathway that makes sense”

    Brigham·1:37:21

  • “The cash pay model is an educated patient who's taking their health into their own hands, and you better believe me when I say, If you don't put a win on the board, they're gonna fire your ass, because it's their money.”

    Brigham·1:23:16

Bearish:

• $PHARMA - Traditional pharmaceutical model facing disruption from peptides, stem cells, and preventative care approaches that don't require billion-dollar approval processes

  • “The system is built to monetize and profiteer off of treating the symptoms of chronic disease. It's become a prescription management system, not a healthcare system.”

    Brigham·29:45

  • “That system got us to one point seven to one point nine million Americans dying every year of chronic disease, more than every world war we've ever fought.”

    Brigham·32:24

  • “We are absolutely an abysmal failure at preventing chronic disease and driving health span.”

    Brigham·34:01

  • “Sixty to eighty percent of the drugs that make it through the drug approval process will have a major label change or recall.”

    Brigham·28:25